Susan D Horn1, Julie Gassaway. 1. International Severity Information Systems, Inc, Institute for Clinical Outcomes Research, Salt Lake City, UT 84102, USA. shorn@isisicor.com
Abstract
BACKGROUND: Comparative effectiveness research analyzes groups of patients and looks for associations between medical treatments and patient outcomes. To make meaningful comparisons of medical interventions, one must consider clinical heterogeneity of patient populations, intervention combinations, and outcomes. OBJECTIVES: To explain how practice-based evidence (PBE) study methodology measures and controls for heterogeneity of patients, treatments, and outcomes seen in real-world clinical settings. RESEARCH DESIGN: Overview of PBE methodology. CONCLUSIONS: PBE study designs address comparative effectiveness by creating a comprehensive set of patient, treatment, and outcome variables, and analyzing them to identify treatments associated with better outcomes for specific types of patients. PBE studies are an alternative to randomized controlled trials, well suited to determine what works best for specific patient types, and provide clinicians with a rational basis for treatment recommendations for individual patients. They provide a holistic picture of patients, treatments, and outcomes, with no preset limits to the number of variables that can be included. Such an approach is needed for high quality comparative effectiveness research.
BACKGROUND: Comparative effectiveness research analyzes groups of patients and looks for associations between medical treatments and patient outcomes. To make meaningful comparisons of medical interventions, one must consider clinical heterogeneity of patient populations, intervention combinations, and outcomes. OBJECTIVES: To explain how practice-based evidence (PBE) study methodology measures and controls for heterogeneity of patients, treatments, and outcomes seen in real-world clinical settings. RESEARCH DESIGN: Overview of PBE methodology. CONCLUSIONS: PBE study designs address comparative effectiveness by creating a comprehensive set of patient, treatment, and outcome variables, and analyzing them to identify treatments associated with better outcomes for specific types of patients. PBE studies are an alternative to randomized controlled trials, well suited to determine what works best for specific patient types, and provide clinicians with a rational basis for treatment recommendations for individual patients. They provide a holistic picture of patients, treatments, and outcomes, with no preset limits to the number of variables that can be included. Such an approach is needed for high quality comparative effectiveness research.
Authors: M Cary Reid; David A Bennett; Wen G Chen; Basil A Eldadah; John T Farrar; Bruce Ferrell; Rollin M Gallagher; Joseph T Hanlon; Keela Herr; Susan D Horn; Charles E Inturrisi; Salma Lemtouni; Yu Woody Lin; Kaleb Michaud; R Sean Morrison; Tuhina Neogi; Linda L Porter; Daniel H Solomon; Michael Von Korff; Karen Weiss; James Witter; Kevin L Zacharoff Journal: Pain Med Date: 2011-08-11 Impact factor: 3.750
Authors: Bruce H K Dobkin; Stephen E Nadeau; Andrea L Behrman; Samuel S Wu; Dorian K Rose; Mark Bowden; Stephanie Studenski; Xiaomin Lu; Pamela W Duncan Journal: J Rehabil Res Dev Date: 2014
Authors: Wendy Gordan; Donald Gerber; Dana Spivack David; Viki Adornato; Rebecca Brougham; Julie Gassaway; Scott E D Kreider; Gale Whiteneck Journal: J Spinal Cord Med Date: 2012-11 Impact factor: 1.985
Authors: Claire Cahow; Julie Gassaway; Cecilia Rider; Joan P Joyce; Andrew Bogenschutz; Andrew Bogenshutz; Kelly Edens; Scott E D Kreider; Gale Whiteneck Journal: J Spinal Cord Med Date: 2012-11 Impact factor: 1.985
Authors: Laura Teeter; Julie Gassaway; Sally Taylor; Jacqueline LaBarbera; Shari McDowell; Deborah Backus; Jeanne M Zanca; Audrey Natale; Jordan Cabrera; Randall J Smout; Scott E D Kreider; Gale Whiteneck Journal: J Spinal Cord Med Date: 2012-11 Impact factor: 1.985
Authors: Gale Whiteneck; Julie Gassaway; Marcel P Dijkers; Allen W Heinemann; Scott E D Kreider Journal: J Spinal Cord Med Date: 2012-11 Impact factor: 1.985